Stryker initiated with an Outperform at William Blair

William Blair initiated coverage of Stryker (SYK) with an Outperform rating and no price target The company has “significantly expanded its reach” beyond knees and hips and capital equipment over the past decade, the analyst tells investors in a research note. The firm sees faster sales and earnings growth over the next two years for Stryker versus peers, led by the company’s “diversified” growth product portfolio.